Nitta Kosaku
   Department   Other, Other
   Position  
Article types Original article
Language English
Peer review Non peer reviewed
Title Elevation of the serum liver enzyme levels during tolvaptan treatment in patients with autosomal dominant polycystic kidney disease (ADPKD).
Journal Formal name:Clinical and experimental nephrology
Abbreviation:Clin Exp Nephrol
ISSN code:(1437-7799)1342-1751(Linking)
Volume, Issue, Page 22(5),pp.1079-1087
Author and coauthor Makabe Shiho, Mochizuki Toshio, Mitobe Michihiro, Aoyama Yumi, Kataoka Hiroshi, Tsuchiya Ken, Nitta Kosaku
Authorship Last author,Corresponding author
Publication date 2018/10
Summary In patients with mild elevation of the serum liver enzyme, as is less than three times the upper limit of normal (ULN), resumption of tolvaptan may be considered after the serum liver enzyme levels return to normal range.
DOI 10.1007/s10157-018-1545-7
PMID 29508162